Skip to main content

Quarterly Result

Rubicon Research Ltd Industry: (Pharmaceuticals - Indian - Formulations)

BSE Code: 544578

ISIN Demat: INE506V01022

Book Value(₹): 81.75

NSE Symbol: RUBICON

Div & Yield(%): 0.09

Market Cap(₹ Cr): 28,415.60

P/E(TTM): 120.71

EPS(TTM): 14.22

Face Value(₹): 1.00

Particulars Jun 2026 (₹ Cr) Mar 2026 (₹ Cr) Dec 2025 (₹ Cr)
Gross Sales 427.73 389.88 301.71
Excise Duty 0.00 0.00 0.00
Net Sales 427.73 389.88 301.71
Other Operating Income 0.00 0.00 0.00
Other Income 2.41 3.58 4.30
Total Income 430.14 393.46 306.01
Total Expenditure 302.90 283.71 239.46
PBIDT 127.24 109.75 66.55
Interest 6.01 5.40 7.51
PBDT 121.23 104.35 59.04
Depreciation 10.57 10.17 9.51
Tax 23.05 29.15 10.12
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 5.16 -4.98 2.23
Reported Profit After Tax 82.45 70.02 37.18
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 82.45 70.02 37.18
EPS (Unit Curr.) 4.99 4.25 2.28
EPS (Adj) (Unit Curr.) 4.99 4.25 2.28
Calculated EPS (Unit Curr.) 4.99 4.24 2.26
Calculated EPS (Adj) (Unit Curr.) 4.99 4.24 2.26
Calculated EPS (Ann.) (Unit Curr.) 19.94 16.97 9.03
Calculated EPS (Adj) (Ann.) (Unit Curr.) 19.94 16.97 9.03
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 16.54 16.51 16.48
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 29.75 28.15 22.06
PBDTM(%) 28.34 26.76 19.57
PATM(%) 19.28 17.96 12.32
Attention Investor :
Prevent Unauthorised Transactions in your Trading / Demat account --> Update your Mobile Number with your Depository Participant